Bryce Point Capital, LLC Dynavax Technologies Corp Transaction History
Bryce Point Capital, LLC
- $133 Billion
- Q1 2025
A detailed history of Bryce Point Capital, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Bryce Point Capital, LLC holds 25,574 shares of DVAX stock, worth $287,963. This represents 0.27% of its overall portfolio holdings.
Number of Shares
25,574Holding current value
$287,963% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
296Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$247 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$200 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$103 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$87.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$73.9 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.42B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...